title: Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer.
abstract: Enhancer of zeste homolog 2 (EZH2) is the histone lysine N-methyltransferase component of the Polycomb repressive complex 2 (PRC2), which, in conjunction with embryonic ectoderm development (EED) and suppressor of zeste 12 homolog, regulates cell lineage determination and homeostasis. Enzymatic hyperactivity has been linked to aberrant repression of tumor suppressor genes in diverse cancers. Here, we report the development of stabilized α-helix of EZH2 (SAH-EZH2) peptides that selectively inhibit H3 Lys27 trimethylation by dose-responsively disrupting the EZH2-EED complex and reducing EZH2 protein levels, a mechanism distinct from that reported for small-molecule EZH2 inhibitors targeting the enzyme catalytic domain. MLL-AF9 leukemia cells, which are dependent on PRC2, undergo growth arrest and monocyte-macrophage differentiation upon treatment with SAH-EZH2, consistent with observed changes in expression of PRC2-regulated, lineage-specific marker genes. Thus, by dissociating the EZH2-EED complex, we pharmacologically modulate an epigenetic 'writer' and suppress PRC2-dependent cancer cell growth.
authors: 1] Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
authors: Woojin
authors: W
authors: Kim
authors: Gregory H
authors: GH
authors: Bird
authors: Tobias
authors: T
authors: Neff
authors: Guoji
authors: G
authors: Guo
authors: Marc A
authors: MA
authors: Kerenyi
authors: Loren D
authors: LD
authors: Walensky
authors: Stuart H
authors: SH
authors: Orkin
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor; D000071221:Enhancer of Zeste Homolog 2 Protein; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008958:Models, Molecular; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D063151:Polycomb Repressive Complex 2 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013329:Structure-Activity Relationship
chemical_list: D000970:Antineoplastic Agents; C491488:EED protein, human; D010455:Peptides; C498409:EZH2 protein, human; D000071221:Enhancer of Zeste Homolog 2 Protein; D063151:Polycomb Repressive Complex 2
references: Cancer Cell. 2013 May 13;23(5):677-92
references: 23680150
references: Blood. 2002 Jun 1;99(11):3939-46
references: 12010792
references: Science. 2002 Nov 1;298(5595):1039-43
references: 12351676
references: Arch Biochem Biophys. 1972 Feb;148(2):558-67
references: 5063076
references: Cell. 2002 Oct 18;111(2):185-96
references: 12408863
references: Cancer Res. 2012 Jan 1;72(1):315-24
references: 22068036
references: Nat Chem Biol. 2010 Aug;6(8):595-601
references: 20562877
references: Cancer Cell. 2010 Oct 19;18(4):316-28
references: 20951942
references: Cell Mol Life Sci. 2005 Aug;62(16):1839-49
references: 15968462
references: J Biol Chem. 1984 Apr 10;259(7):4353-8
references: 6707008
references: Science. 2008 Dec 12;322(5908):1695-9
references: 19008416
references: Structure. 2007 Oct;15(10):1306-15
references: 17937919
references: J Biol Chem. 2008 Jun 20;283(25):17324-32
references: 18430739
references: Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11606-11
references: 14500907
references: J Pathol. 2008 Jun;215(2):175-83
references: 18393368
references: Pharmacol Ther. 1998 Feb;77(2):115-34
references: 9578320
references: Nature. 2012 Dec 6;492(7427):108-12
references: 23051747
references: Leuk Res. 2012 Aug;36(8):1049-54
references: 22472464
references: Cell. 2009 Dec 24;139(7):1303-14
references: 20064376
references: Mol Cell. 2008 Nov 21;32(4):491-502
references: 19026780
references: Nature. 2009 Nov 12;462(7270):182-8
references: 19907488
references: Cancer Cell. 2007 Nov;12(5):419-31
references: 17996646
references: Genes Dev. 2011 Mar 1;25(5):485-98
references: 21317239
references: Cell. 2002 Oct 18;111(2):197-208
references: 12408864
references: Genes Dev. 2002 Nov 15;16(22):2893-905
references: 12435631
references: Oncogene. 2013 Feb 14;32(7):930-8
references: 22469984
references: Nature. 2004 Nov 18;432(7015):396-401
references: 15549107
references: Nat Chem Biol. 2012 Nov;8(11):890-6
references: 23023262
references: Nature. 2002 Oct 10;419(6907):624-9
references: 12374981
references: Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8
references: 20660316
references: Biochem Biophys Res Commun. 2006 Dec 29;351(4):820-4
references: 17097610
references: Genes Dev. 2007 May 1;21(9):1050-63
references: 17437993
references: Mol Cancer Ther. 2009 Jun;8(6):1579-88
references: 19509260
references: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2989-94
references: 22323599
references: Science. 2012 Dec 14;338(6113):1465-9
references: 23239736
references: PLoS One. 2011;6(7):e21651
references: 21765901
references: Biochim Biophys Acta. 2004 Mar 15;1677(1-3):52-7
references: 15020045
references: Stem Cells. 2008 Jun;26(6):1496-505
references: 18403752
references: Cancer Cell. 2012 Jul 10;22(1):9-20
references: 22789535
references: Science. 2004 Sep 3;305(5689):1466-70
references: 15353804
references: Genes Dev. 2007 Mar 1;21(5):525-30
references: 17344414
references: Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5028-33
references: 22396593
references: Nature. 2006 Aug 17;442(7104):818-22
references: 16862118
references: Stem Cells. 2005 Sep;23(8):1142-53
references: 16140871
references: Nature. 2010 Jan 28;463(7280):474-84
references: 20110991
references: Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17016-21
references: 21969581
references: Pharmacol Rev. 2006 Sep;58(3):621-81
references: 16968952
references: Mol Cell. 2006 Oct 20;24(2):199-210
references: 17052454
references: Int J Cancer. 2010 Jul 1;127(1):138-47
references: 19904743
references: Mol Cell. 2011 Sep 2;43(5):798-810
references: 21884980
references: Nat Genet. 2010 Feb;42(2):181-5
references: 20081860
references: PLoS One. 2012;7(3):e33729
references: 22442719
references: Mol Cell. 2008 Nov 21;32(4):503-18
references: 19026781
references: J Cancer Res Clin Oncol. 2008 Mar;134(3):331-6
references: 17694325